drugset / Trial / NCT05196191

Wound Healing Following Penile Prosthesis Implant

NCT05196191 ↗

Terminated 32 enrolled VIVEX Biologics, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective, randomized, clinical study aimed to evaluate the safety and efficacy of the two treatment schedules on men undergoing penile implant surgery for the first time. The patients are randomized in a 2:1 ratio of active to sham treatment groups.

Timeline

Start
2022-01-03
Primary completion
2023-12-13
Completion
2023-12-30

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject VIAGENEX Max Other / unclassified — —

Indications